Outlook Therapeutics, Inc. (OTLK) News Headlines

▮ More

Date

Headline

7/7/2020 8:08:14 AM Outlook Therapeutics Completes Patient Enrollment In NORSE 2 Clinical Trial For ONS-5010 / LYTENAVA

6/17/2020 8:12:42 AM Outlook Therapeutics Provides Clinical Update On ONS-5010 / LYTENAVA

4/14/2020 8:25:46 AM Outlook Therapeutics Provides COVID-19 Impact Update On Impact Of The COVID-19 Pandemic On Status Of NORSE 1 And NORSE 2

2/24/2020 8:07:16 AM Outlook Therapeutics Reports $10.2 Mln Financings Priced At-The-Market

1/28/2020 8:22:22 AM Outlook Therapeutics Enters Agreements With BioLexis

12/26/2019 8:04:47 AM Outlook Therapeutics Completes Previously Announced Warrant Restructuring

12/19/2019 8:13:16 AM Outlook Therapeutics FY Net Loss Attributable $36.0 Mln Or $1.98 Per Share

12/3/2019 8:38:26 PM Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch

8/28/2019 10:36:39 PM 6 Top Gainers In Healthcare Sector (LCI, PSTV, OTLK…)

8/27/2019 1:07:29 AM 5 Top Losers In Healthcare Sector (PTE, NSPR, OTLK…)

8/20/2019 8:06:54 AM Outlook Therapeutics Completes Patient Enrollment For NORSE 1 A Phase 3 Clinical Trial For ONS-5010 In Wet AMD

7/18/2019 10:30:05 PM 5 Top Gainers In Healthcare Sector (OTLK, NEPT, EOLS...)

7/16/2019 8:17:05 AM Outlook Therapeutics Doses First Patient In ONS-5010-002 Phase 3 Clinical Trial

5/20/2019 10:21:44 PM 5 Top Gainers In Pharma Sector (OTLK, SESN, UROV...)

5/17/2019 2:19:10 AM AIMT To Face FDA Panel In Sep., FDA Lifts Hold On ADVM Trial, OTLK Jumps

4/10/2019 11:33:52 PM 6 Top Losers In Healthcare Sector (OTLK, WVE, PHAS…)

4/10/2019 9:13:18 AM Outlook Therapeutics Prices Public Offering Of 10.34 Mln Common Shares

2/14/2019 8:32:37 PM 7 Top Gainers In Healthcare Sector (IVC, OTLK, MDGL...)

Older Articles